跳至主要内容
临床试验/NCT00482872
NCT00482872已完成不适用

Familial HNSCC Syndrome and p16 Germline Mutations

Vanderbilt University Medical Center3 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2004年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
3
主要终点
Incidence of INK4a-p16 germline mutations

研究概览

简要总结

RATIONALE: Studying gene mutations in samples of DNA from patients with head and neck cancer and a family history of cancer may help doctors learn more about the development of cancer in families.

PURPOSE: This clinical trial is studying germline mutations in patients with head and neck cancer and a family history of cancer.

详细描述

OBJECTIVES:

  • Measure the incidence of p16^INK4a germline mutations in patients with squamous cell carcinoma of the head and neck and a family history of cancer.
  • Determine biologic activity of identified p16^INK4a germline mutations.

OUTLINE: DNA specimens are collected for genetic and mutation analysis and examined by PCR and flow cytometry. The activity of cells with p16 mutations is determined by cell cycle arrest functional assay.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Incidence of INK4a-p16 germline mutations

Biologic activity of identified INK4a-p16 germline mutations

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验